In our hands, the synergistic combination of mechanistically distinct effector domains (EDs), such as VPR and MS2-MCP-p65-HSF1, is a powerful tool to endogenously reactivate silenced TSGs in HCC cell lines. Here, ADAM8 is linked to hepatocellular carcinoma.